No Data
No Data
United Therapeutics(UTHR.US) Officer Sells US$3.02 Million in Common Stock
United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025
United Therapeutics(UTHR.US) Director Sells US$4.76 Million in Common Stock
Express News | Form 144 | United Therapeutics(UTHR.US) Director Proposes to Sell 4.76 Million in Common Stocks
Argus Research Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $375
Leerink Partners Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $420